Top Menu HELP dot CONTACT US dot LOGIN  

www.leo-sarath.com // SITEMAP
 

LEO Global
  • United Kingdom

  • The Netherlands

  • Switzerland

  • Sweden

  • Spain

  • Portugal

  • Norway

  • Latin America

  • Japan

  • Ireland

  • Greece

  • Germany

  • Middle East

  • France

  • Finland

  • Denmark

  • Canada

  • Belgium

  • Austria

  • Asia


    • SITEMAP

    HELP

    CONTACT US

    Newsletters

    Disclaimer

    About LEO Sarath
  • Company Overview

  • LPI-Athens Organogram

  • Local Sales Offices

  • LEO Distributors

  • Dedicated to Leadership in Dermatology

  • LEO Fundamentals

  • The history of LEO Pharma


    • Contact Us

    Physicians Memberships & Benefits

    For Medical Professionals ONLY
  • Drug Safety


    • LEO Training Academy (L.T.A.)
  • About LEO Training Academy

  • Behavioral Style Workshop (24th – 30th October 2009)


    • PATIENT EDUCATION MATERIAL
  • Eczema

  • Arabic

  • English

  • Diet Program for Renal Failure Patients

  • Arabic

  • English

  • Psoriasis

  • Arabic

  • English

  • Renal Bone Disease. How does it work?

  • Arabic

  • English

  • Bone Metabolism in Renal Failure Patients

  • Arabic

  • English

  • Venous Thromboembolism

  • Arabic

  • English

  • General information for dialysis patients

  • General information after the fistula operation for the patients of kidney failure

  • Instructions for the patient

  • Daivonex® Scalp solution

  • Daivonex® Adult prescribing guide

  • Coagulation in haemodialysis

  • Innohep® in Haemodialysis


    • Seek for a second opinion!
  • Renal Osteodystrophy - FREE Consultation

  • Meet our Expert!


    • Other LEO websites

    Discussion Forum

    Stop receiving Newsletter

    Ask Your Question
  • Osteoporosis

  • Renal Failure

  • Psoriasis

  • Atopic Eczema

  • Anticoagulation

  • Bacterial Eye Infection

  • Pleiotropic Effects

  • Haemodialysis

  • Other

    • For additional information or comments please contact: 

    Mrs. Evie Smyrnopoulou 
    IT/Web Coordinator 

    evie.smyrnopoulou@leo-pharma.com 

    		  
     

    Login to Restricted Web Area
    Email:
    Password:
     
     
    News
    12-11-2009 - LEO Pharma Completes Peplin Acquisition
     Danish LEO Pharma has gained additional ground in the US after finalising the agreement to acquire Australian-US Peplin, Inc. Read More

    1-10-2009 - LEO Pharma acquires own portfolio in the US
    LEO Pharma A/S, a world leader in treatment of dermatological diseases, has re-acquired the US-rights to the company’s psoriasis portfolio and dermatology pipeline from the previous partner in the US, Warner Chilcott. The transaction sum is set at... Read More

    1-1-2009 - LEARN MORE ABOUT...
     Patient Educational Material Read More
    SITEMAP Disclaimer Privacy Policy
    LEO Pharmaceutical Products Sarath LTD . 5, Himaras street . 3rd floor . GR-151 25 Marousi . Athens . Greece. Tel: +30 210 9954545 . Fax: +30 210 9940565 .
    E-mail: leo.roa@leo-pharma.com